• New Arrivals
  • Sale
  • Hot items

Numbuzin No.9 NAD+ Retinol Volumetox Eye Cream

Brand: NUMBUZIN

Rs 6,000

3 X Rs. 2,000.00 or 5% Cashback with mintpay_info_icon_woocommerce

or 3 X Rs 2,000.00 with Koko

Out of stock

Email when stock available

  • Check Mark Estimated Delivery : 1 to 3 working days
  • Check Mark 10% Discount for COD & Bank Transfer
  • Check Mark Current Batches Expire In 2028/2029
  • Check Mark 100% Authenticity Guaranteed

The numbuzin No.9 NAD+ Retinol Volumetox Eye Cream is a targeted treatment for the delicate eye area, designed to improve the look of fine lines, dullness, and loss of firmness.

This formula combines a gentle form of retinol with a multi-peptide complex to help smooth the appearance of wrinkles and support firmer-looking skin over time. Niacinamide helps brighten the under-eye area and improve uneven tone, while ceramides support the skin barrier and prevent moisture loss.

It also includes NAD+, which helps maintain overall skin condition and hydration, keeping the eye area soft and comfortable.

The cream has a smooth texture that absorbs easily without feeling heavy, making it suitable for both day and night use.

Key Benefits

  • Helps soften the appearance of fine lines and wrinkles
  • Supports firmer-looking under-eye skin
  • Brightens dark circles and uneven tone
  • Provides hydration and barrier support
  • Comfortable texture suitable for daily use

Key Ingredients

  • Retinol: Helps improve the look of fine lines
  • Peptides (multiple types): Support skin firmness
  • Niacinamide: Helps brighten and even out tone
  • Ceramides: Help strengthen the skin barrier
  • NAD+: Supports skin hydration and condition

Who It’s For

  • Fine lines and early signs of aging around the eyes
  • Dark circles or dull under-eye area
  • Dry or tired-looking eyes
  • Suitable for most skin types (introduce slowly if sensitive)

How to Use

Apply a small amount around the eye area and gently tap until absorbed. Start with evening use and adjust based on skin tolerance.